Consensus XORTX Therapeutics Inc.

Equities

XRTX

CA98420Q3061

Market Closed - Toronto S.E. Other stock markets 11:22:23 2024-05-02 am EDT			5-day change	1st Jan Change
3.4 ^CAD	-3.68%		-13.92%	+17.24%

Apr. 22	XORTX Therapeutics Announces Publication of Key Research in ADPKD in Peer-reviewed Journal	MT
Apr. 08	XORTX Therapeutics Inc. Appoints Abigail Jenkins to the Board of Directors	CI

Evolution of the average Target Price on XORTX Therapeutics Inc.

Price target over the last 5 years

History of analyst recommendation changes

6a05bf580ad5156364265b7a.t9yKR1w6iKaNV0H0eUqxXoNb4IJPOlWn8PflMulxhFM.7_HaBgNXsN7IOgO7IQmJCPIftbQmXB7Xnpm_ftAX4mGOlu0hNxfe0cETIg~b42f04ffa76c1e2b33f227070634686e

Analyst Recommendations on XORTX Therapeutics Inc.

Wall Street Set for Losses as Rate Hike Fears Resurface Ahead of Jackson Hole	22-08-22	MT
Alliance Global Partners Initiates XORTX Therapeutics at Buy Rating With $11 Price Target	21-12-09	MT